Joseph C. Ruiz
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$1.2MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 12, 2022 | NIH | SBIR Phase II Development of allele-specific protein-based therapeutic targeting the pathogenic RNA associated with Spinocerebellar ataxia type 3 | $259K | ENZERNA BIOSCIENCES LLC |
| Jul 17, 2020 | NIH | SBIR Phase I Protein-based Therapeutics to treat nucleotide expansion disorders associated with aberrant gene expression | $231K | ENZERNA BIOSCIENCES LLC |
| Aug 30, 2019 | NIH | SBIR Phase I Ablation of the pathogenic RNA transcript associated with myotonic dystrophy, DM1 | $224K | ENZERNA BIOSCIENCES LLC |
| Sep 5, 2017 | NIH | STTR Phase I Creation of animal models of mitochondrial DNA disease for translational research applications | $224K | ENZERNA BIOSCIENCES LLC |
| Feb 3, 2016 | NIH | SBIR Phase I Novel tools for site-specific ablation of the mitochondrial genome | $225K | ENZERNA BIOSCIENCES LLC |
Peer ranks
Federal funding#1,619
Awards as PI#417
Patents#273
Companies
- ENZERNA BIOSCIENCES LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.